Cargando…
Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
AIM: This study aimed to explore the expression pattern of MLLT11 under different pathological features, evaluate its prognostic value for glioma patients, reveal the relationship between MLLT11 mRNA expression and immune cell infiltration in the tumor microenvironment (TME), and provide more eviden...
Autores principales: | Chen, Long, Xiong, Zujian, Zhao, Hongyu, Teng, Chubei, Liu, Hongwei, Huang, Qi, Wanggou, Siyi, Li, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414891/ https://www.ncbi.nlm.nih.gov/pubmed/36033495 http://dx.doi.org/10.3389/fonc.2022.889351 |
Ejemplares similares
-
Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
por: Lin, Xuelei, et al.
Publicado: (2022) -
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022) -
Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma
por: Teng, Chubei, et al.
Publicado: (2021) -
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
por: Xiong, Yi, et al.
Publicado: (2020) -
Clinical characteristics, surgical management, and prognostic factors for supratentorial hemangioblastoma: A retrospective study
por: Chen, Long, et al.
Publicado: (2023)